StockNYSEABBV
AbbVie
$283.40
-2.06 (-0.72%)today
Valuation & earnings
- P/E ratio
- 80.06
- Forward P/E
- 17.48
- EPS (ttm)
- $3.54
- Forward EPS
- $16.22
- Price/book
- -84.37
- PEG ratio
- 0.58
- Dividend yield
- 2.52%
- Payout ratio
- 190.4%
Financials (ttm)
- Revenue (ttm)
- 64.4B
- Revenue growth
- 10.2%
- Profit margin
- 9.8%
- Total cash
- 6.6B
- Total debt
- 70.9B
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 1.78 | 1.86 | +4.23% |
| Dec 31, 2025 | 2.65 | 2.71 | +2.16% |
| Mar 31, 2026 | 2.67 | 2.65 | -0.77% |
| Jun 30, 2026 | 3.61 | 3.65 | +1.15% |
Next earnings date: Oct 30, 2026
Analyst view
Consensus ratingBuy30 analysts
Strong buy 8Buy 16Hold 5Strong sell 1
12-month price targetsImplied upside: -0.28%
200
282.61
328
LowCurrent priceHigh
Dividends
- Dividend yield
- 2.52%
- Ex-dividend date
- Oct 15, 2026
Recent payments
Jul 15, 2026 · $1.73Apr 15, 2026 · $1.73Jan 16, 2026 · $1.73Oct 15, 2025 · $1.64Jul 15, 2025 · $1.64
Related products
How visible is AbbVie in AI search?
We ask AI search engines about AbbVie and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for AbbVie yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.